• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡啶甲酸在体外调节红藻氨酸诱发的纹状体谷氨酸释放。

Picolinic acid modulates kainic acid-evoked glutamate release from the striatum in vitro.

作者信息

Vrooman L, Jhamandas K, Boegman R J, Beninger R J

机构信息

Department of Pharmacology and Toxicology, Queen's University, Kingston, Ont., Canada.

出版信息

Brain Res. 1993 Nov 12;627(2):193-8. doi: 10.1016/0006-8993(93)90320-m.

DOI:10.1016/0006-8993(93)90320-m
PMID:7905351
Abstract

Since picolinic acid, a tryptophan metabolite yielded by the kynurenine pathway, selectively attenuates quinolinic and kainic acid excitotoxicity that is dependent on the presence of a glutamatergic afferent input, it was hypothesized that this agent may inhibit the presynaptic release of glutamate. Using superfused rat striatal slices, this study examined the potential of picolinic acid, and related pyridine monocarboxylic acids, to modify kainic acid-induced glutamate release. Kainic acid (0.25, 0.5 and 1.0 mM) stimulated the release of glutamate, an effect which was calcium dependent and was attenuated in the presence of the kainate/AMPA receptor antagonist, 6,7-dinitroquinoxalene-2,3-dione (500 microM). Picolinic acid significantly decreased glutamic acid release evoked by exposure of striatal slices to 1 mM kainate in the presence of calcium. The inhibitory action of picolinic acid on kainate-induced release was also shared by nicotinic and isonicotinic acid. In the absence of external calcium, kainic acid-induced glutamate release was significantly reduced by approximately 65%. Under this condition, picolinic acid (100 microM) failed to influence kainic acid-induced release. Picolinic acid (100 microM) itself increased glutamate release by 35% over basal release. While the ability of picolinic acid to inhibit excitotoxin-induced release supports the notion that it may act presynaptically to modify excitotoxicity, lack of structural specificity in its action tends to cast doubt on this mechanism of action.

摘要

由于犬尿氨酸途径产生的色氨酸代谢产物吡啶甲酸可选择性减轻喹啉酸和红藻氨酸的兴奋性毒性,这种兴奋性毒性依赖于谷氨酸能传入输入的存在,因此推测该药物可能抑制谷氨酸的突触前释放。本研究使用灌流的大鼠纹状体切片,检测了吡啶甲酸及相关吡啶单羧酸改变红藻氨酸诱导的谷氨酸释放的可能性。红藻氨酸(0.25、0.5和1.0 mM)刺激了谷氨酸的释放,这一效应依赖于钙,并且在红藻氨酸/AMPA受体拮抗剂6,7-二硝基喹喔啉-2,3-二酮(500 microM)存在时减弱。在有钙的情况下,吡啶甲酸显著降低了纹状体切片暴露于1 mM红藻氨酸时诱发的谷氨酸释放。烟酸和异烟酸也具有吡啶甲酸对红藻氨酸诱导释放的抑制作用。在无细胞外钙的情况下,红藻氨酸诱导的谷氨酸释放显著降低了约65%。在此条件下,吡啶甲酸(100 microM)未能影响红藻氨酸诱导的释放。吡啶甲酸(100 microM)本身使谷氨酸释放量比基础释放量增加了35%。虽然吡啶甲酸抑制兴奋性毒素诱导释放的能力支持了它可能通过突触前作用来改变兴奋性毒性的观点,但其作用缺乏结构特异性这一点往往让人对这种作用机制产生怀疑。

相似文献

1
Picolinic acid modulates kainic acid-evoked glutamate release from the striatum in vitro.吡啶甲酸在体外调节红藻氨酸诱发的纹状体谷氨酸释放。
Brain Res. 1993 Nov 12;627(2):193-8. doi: 10.1016/0006-8993(93)90320-m.
2
Action of picolinic acid and structurally related pyridine carboxylic acids on quinolinic acid-induced cortical cholinergic damage.吡啶甲酸及结构相关的吡啶羧酸对喹啉酸诱导的皮质胆碱能损伤的作用。
Brain Res. 1992 Dec 18;599(1):57-63. doi: 10.1016/0006-8993(92)90852-z.
3
2-chloroadenosine attenuates kainic acid-induced toxicity within the rat straitum: relationship to release of glutamate and Ca2+ influx.2-氯腺苷减轻红藻氨酸诱导的大鼠纹状体毒性:与谷氨酸释放和钙离子内流的关系
Br J Pharmacol. 1989 Sep;98(1):225-35. doi: 10.1111/j.1476-5381.1989.tb16886.x.
4
Dissociation between the excitatory and "excitotoxic" effects of quinolinic acid analogs on the striatal cholinergic interneuron.
J Pharmacol Exp Ther. 1985 Mar;232(3):873-82.
5
Potentiation by kainate of excitatory amino acid release in striatum: complementary in vivo and in vitro experiments.海人酸对纹状体中兴奋性氨基酸释放的增强作用:体内和体外互补实验
J Neurochem. 1988 Feb;50(2):337-45. doi: 10.1111/j.1471-4159.1988.tb02918.x.
6
In vivo microdialysis studies on the effects of decortication and excitotoxic lesions on kainic acid-induced calcium fluxes, and endogenous amino acid release, in the rat striatum.关于去皮质和兴奋性毒性损伤对大鼠纹状体内海人酸诱导的钙通量及内源性氨基酸释放影响的体内微透析研究。
J Neurochem. 1987 Nov;49(5):1355-60. doi: 10.1111/j.1471-4159.1987.tb00999.x.
7
The effect of kainic, quinolinic and beta-kainic acids on the release of endogenous amino acids from rat brain slices.
Biochem Pharmacol. 1986 Oct 15;35(20):3631-5. doi: 10.1016/0006-2952(86)90636-2.
8
Regulation of NMDA-stimulated [14C]GABA and [3H]acetylcholine release by striatal glutamate and dopamine receptors.纹状体谷氨酸和多巴胺受体对N-甲基-D-天冬氨酸刺激的[14C]γ-氨基丁酸和[3H]乙酰胆碱释放的调节
Brain Res. 1999 Oct 9;844(1-2):106-17. doi: 10.1016/s0006-8993(99)01869-7.
9
Met-enkephalin release from slices of the rat striatum and globus pallidus: stimulation by excitatory amino acids.甲硫氨酸脑啡肽从大鼠纹状体和苍白球切片中的释放:兴奋性氨基酸的刺激作用。
J Pharmacol Exp Ther. 1991 Jun;257(3):1025-33.
10
Two functionally different glutamate receptors of the kainate subtype in embryonic rat mesencephalic cells.
Exp Neurol. 1993 Apr;120(2):202-13. doi: 10.1006/exnr.1993.1055.

引用本文的文献

1
Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities.神经活性色氨酸代谢产物作为药理学靶点:新的实验工具和令人兴奋的治疗机会。
Pharmacol Rev. 2024 Oct 16;76(6):978-1008. doi: 10.1124/pharmrev.124.000239.
2
The immunosuppressive role of indoleamine 2, 3-dioxygenase in glioblastoma: mechanism of action and immunotherapeutic strategies.吲哚胺 2,3-双加氧酶在胶质母细胞瘤中的免疫抑制作用:作用机制和免疫治疗策略。
Med Oncol. 2022 Jun 18;39(9):130. doi: 10.1007/s12032-022-01724-w.
3
Kynurenine Pathway Metabolites as Biomarkers in Alzheimer's Disease.
犬尿氨酸途径代谢产物作为阿尔茨海默病的生物标志物。
Dis Markers. 2022 Jan 19;2022:9484217. doi: 10.1155/2022/9484217. eCollection 2022.
4
The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors.犬尿氨酸途径和犬尿氨酸 3-单加氧酶抑制剂。
Molecules. 2022 Jan 2;27(1):273. doi: 10.3390/molecules27010273.
5
Peripheral and central kynurenine pathway abnormalities in major depression.外周和中枢色氨酸代谢途径异常与重度抑郁症。
Brain Behav Immun. 2022 Mar;101:136-145. doi: 10.1016/j.bbi.2022.01.002. Epub 2022 Jan 6.
6
Neuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications.神经炎症与中枢神经系统疾病中的犬尿氨酸途径:分子机制与治疗意义。
Cells. 2021 Jun 19;10(6):1548. doi: 10.3390/cells10061548.
7
Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period.发作性偏头痛患者抑郁型犬尿氨酸通路的临床相关性:间歇期外周血浆中的潜在预后标志物。
J Headache Pain. 2021 Jun 25;22(1):60. doi: 10.1186/s10194-021-01239-1.
8
IDO and Kynurenine Metabolites in Peripheral and CNS Disorders.色氨酸代谢物 IDO 和犬尿氨酸在周围和中枢神经系统疾病中的作用。
Front Immunol. 2020 Mar 5;11:388. doi: 10.3389/fimmu.2020.00388. eCollection 2020.
9
Changing the face of kynurenines and neurotoxicity: therapeutic considerations.犬尿氨酸与神经毒性的面貌改变:治疗方面的考量
Int J Mol Sci. 2015 Apr 29;16(5):9772-93. doi: 10.3390/ijms16059772.
10
Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases.具有神经活性和氧化还原特性的犬尿氨酸:与衰老和脑部疾病的关联
Oxid Med Cell Longev. 2014;2014:646909. doi: 10.1155/2014/646909. Epub 2014 Feb 17.